Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Multiple Myeloma 11Recurrence 3Leukemia, Myeloid, Acute 3Breast Neoplasms 2Waldenstrom Macroglobulinemia 1Triple Negative Breast Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Mantle-Cell 1Lymphoma, B-Cell 1Lymphoma 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Biphenotypic, Acute 1Leukemia 1Genetic Diseases, Inborn 1Congenital Abnormalities 1Carcinoma, Renal Cell 1

Interventions

fludarabine phosphate 3Doxorubicin 3Cytarabine 3venetoclax 2Vincristine 2Mycophenolic Acid 2Filgrastim 2Dexamethasone 2Cyclophosphamide 2Calcium Dobesilate 2pegaspargase 1obatoclax 1lirilumab 1liposomal doxorubicin 1ixazomib 1fludarabine 1blinatumomab 1asparaginase erwinia chrysanthemi recombinant 1Whole-Body Irradiation 1Vorinostat 1Tetradecanoylphorbol Acetate 1Tacrolimus 1Sunitinib 1Razoxane 1Radiotherapy 1Platelet Transfusion 1Peripheral Blood Stem Cell Transplantation 1Oxycodone 1Moxifloxacin 1Morphine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Leukemia, Biphenotypic, Acute × ixazomib × Clear all
NCT01887587 2020-01-22

Vincristine, Doxorubicin, And Dexamethasone + Ixazomib in Acute Lymphoblastic Leukemia (ALL), Lymphoblastic Lymphoma Or Mixed Phenotype Acute Leukemia

Medical College of Wisconsin

Phase 1 Terminated
5 enrolled 9 charts
LymphoidOther hematologic neoplasm

Recurrence, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡